As the gold standard for diagnosing Pause, Afib and other arrhythmias is to elucidate the symptom-electrocardiograph (ECG) correlation. ECG monitoring is an established procedure in the evaluation and monitoring of patients with those abnormalities. The ECG recordings during those diseases allow physicians to confirm or exclude a Pause, Afib or other types of arrhythmias. Many studies have investigated the use of internal loop recorders (ILR), while there are recent studies of external loop recorders (ELR) for patients with unexplained syncope.

Unfortunately, ILRs carry the risk of pocket infections that resolve with device explanation. This complication, which can occur either in the peri-procedural phase or later during the follow-up, was reported in 1 to 5% of patients. Another disadvantage of ILR includes the presence of under-sensing or over-sensing.

And considering that the diagnostic yield of ELR was higher than standard 24h-Holter monitoring, it was similar to the diagnostic yield of ILR in the same timeframe. However, the limitations of ELR are patient compliance, failure to operate the device correctly, and difficulties handling cutaneous patch electrodes.

We believe that with the CM 100 technology we overcome all these limitations and, several cost-effectiveness analysis has indicated that the improvement in diagnostic yield offsets the cost of the ELR and that they are an economically attractive alternative when compared to Holter monitoring and the use of ELR could be viewed as a first-choice tool for patients with early recurrence of Pause, Afib and other Arrhythmias types and should be considered for patients for long-term ECG monitoring before ILR.

And for PM 100:

The detection of cardiac arrhythmias is a challenge to doctors and patients alike. Infrequent and irregular episodes are especially hard to diagnose. To overcome this challenge, Tele-ECG’s are being used more and more in everyday situations.

Numerous national and international clinical studies, especially on atrial fibrillation, have been performed using Tele-ECG devices, not least for their high diagnostic yield. The devices enable the patient to independently record short ECG stripes, irrespective of time and place, and automatically send them to their attending physician. A possible arrhythmia can be detected in a timely manner and the patient promptly provided with a suitable treatment.

PhysioMem PM 100, the new generation of Tele ECG equipment, unites modern design, high quality and reliability with ease of use, flexibility and mobility. The device is the result of more than 15 years of experience in the development of Tele ECG equipment and perfectly addresses the numerous challenges faced when trying to diagnose cardiac arrhythmias. The server-based ReSTA system (Remote System for Telemedical Applications) operates around the clock and receives the ECG data sent by the patient. The data is automatically analyzed and the resulting report is redirected to the attending physician. PhysioMem’s integrated GSM module allows ECG data to be transmitted across the globe. 

Our Other


Our product range exceeds over 200 items imported from:



Opera is a sterile medical device, injectable, apirogenic, absorbable, based on cross-linked hyaluronic acid derived from bacterial fermentation. The crosslinking …

Learn More →


Silhouette Soft is a thread lift treatment with a dual lift-and-collagen regenerating effect. Reshape your confidence Silhouette Soft® is a …

Learn More →


Laboratorios BABÉ is an international brand recommended by pharmacists, dermatologists and pediatricians in 55 countries. Present on four continents through …

Learn More →


Ellanse is a unique dermal filler that works by correcting the wrinkles and folds in the skin, but also by …

Learn More →